ZA83640B - Ozone inactivated organisms as vaccines - Google Patents

Ozone inactivated organisms as vaccines

Info

Publication number
ZA83640B
ZA83640B ZA83640A ZA83640A ZA83640B ZA 83640 B ZA83640 B ZA 83640B ZA 83640 A ZA83640 A ZA 83640A ZA 83640 A ZA83640 A ZA 83640A ZA 83640 B ZA83640 B ZA 83640B
Authority
ZA
South Africa
Prior art keywords
vaccines
ozone
inactivated
inactivated organisms
microorganism
Prior art date
Application number
ZA83640A
Other languages
English (en)
Inventor
Chung Zee Yuan
David C Bolton
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of ZA83640B publication Critical patent/ZA83640B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161Methods of inactivation or attenuation
    • C12N2760/16163Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA83640A 1982-02-09 1983-01-31 Ozone inactivated organisms as vaccines ZA83640B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34856982A 1982-02-09 1982-02-09

Publications (1)

Publication Number Publication Date
ZA83640B true ZA83640B (en) 1984-03-28

Family

ID=23368584

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA83640A ZA83640B (en) 1982-02-09 1983-01-31 Ozone inactivated organisms as vaccines

Country Status (10)

Country Link
EP (1) EP0086071B1 (de)
JP (1) JPS58201721A (de)
AT (1) ATE16348T1 (de)
AU (1) AU558008B2 (de)
CA (1) CA1212320A (de)
DE (1) DE3361138D1 (de)
DK (1) DK52783A (de)
IL (1) IL67818A (de)
NZ (1) NZ203094A (de)
ZA (1) ZA83640B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3345864A1 (de) * 1983-12-19 1985-06-27 Egbert Frh. von 8000 München Malsen-Ponickau Impfstoff und verfahren zu seiner herstellung
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
DE3679298D1 (de) * 1985-12-20 1991-06-20 Du Pont Herstellung von tabletten aus mikrobiologischen substanzen.
FR2603805A1 (fr) * 1986-09-16 1988-03-18 Transfusion Sanguine Assoc Rgl Procede d'inactivation par ozonolyse de micro-organismes contaminants presents dans des materiaux biologiques essentiellement proteiques, les produits obtenus et leurs applications biologiques et analytiques
GB0603749D0 (en) * 2006-02-24 2006-04-05 Moving Sun Ltd Immune system stimulant and process of manufacturing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE471250A (de) *
CH173194A (de) * 1933-05-27 1934-11-15 Veterinaria A G Zuerich Verfahren zur Herstellung eines Impfstoffes zur aktiven Immunisierung von Menschen oder Tieren gegen anaerobe Krankheitskeime.
CH200180A (de) * 1936-03-26 1938-09-30 Frei Walter Dr Prof Verfahren zur Herstellung von Vaccinen.
GB1230414A (de) * 1968-07-09 1971-05-05

Also Published As

Publication number Publication date
IL67818A0 (en) 1983-06-15
DE3361138D1 (en) 1985-12-12
CA1212320A (en) 1986-10-07
DK52783D0 (da) 1983-02-08
EP0086071A1 (de) 1983-08-17
DK52783A (da) 1983-08-10
JPS58201721A (ja) 1983-11-24
AU558008B2 (en) 1987-01-15
EP0086071B1 (de) 1985-11-06
AU1081283A (en) 1983-08-18
ATE16348T1 (de) 1985-11-15
IL67818A (en) 1987-03-31
NZ203094A (en) 1986-04-11

Similar Documents

Publication Publication Date Title
IL107474A0 (en) Urease-based vaccine against helicobacter infection
DE3170913D1 (en) Vaccinal complex containing a specific antigen and vaccine containing it
AU7763294A (en) Live in ovo vaccine
ES2092306T3 (es) Adyuvante para vacunas.
EP0145783A4 (de) Impfstoff gegen hundecoronavirus.
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
AU2152988A (en) Intranasal vaccination of horses with inactivated microorganisms or antigenic material
NZ287385A (en) Antigenic preparation comprising the catalase of helicobacter bacteria and vaccines used to treat helicobacter infection
ES2244617T3 (es) Vacunas a base de salmonelas en las cuales los genes ssa han sido inactivados.
DE3361138D1 (en) Ozone inactivated organisms as vaccines
DK1666057T3 (da) Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
AU2521792A (en) Chicken anaemia agent vaccine
EP0090660A3 (de) Neisseria Gonorrhöe Vakzin
EP0256792A3 (en) Vaccines for fowl colibacillosis
GB9018061D0 (en) Compositions for vaccines
EP0636030A4 (de) Impfstoff gegen das bacterientoxoid aus -i (pasteurellia haemolytica).
JPS5781417A (en) Human immunity effect imparting vaccine against escherichia coli infectious desease
JPS5287221A (en) Preventive for chicken dinfections
RU93005000A (ru) Композиция вакцин, способ ее получения, способ исключения иммунной реакции
IL106903A (en) Bacterial vaccines using vaccine strains of pathogenic bacteria
EP0178928A3 (de) Impfstoffe